Advertisement.
Advertisement.
Advertisement
Advertisement.
GOVX Geovax Labs Inc
12,618
| Market Cap | $13.14M |
| Volume | 264,934.00 |
| 52-Wk High | $9.75 |
| 52-Wk Low | $1.09 |
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...
Globe Newswire•4 months ago
ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
Globe Newswire•4 months ago
ATLANTA, GA, March 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
Globe Newswire•5 months ago
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire GeoVax Labs, Inc...
Globe Newswire•5 months ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on GeoVax Labs (GOVX Research Report), Madrigal Pharmaceuticals...
TipRanks Financial Blog•5 months ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly•5 months ago
Progress across the pipeline in multiple clinical trials, includingPhase 2 program of GEO-CM04S1, next-generation Covid-19 vaccine, andmulticenter Phase 1/2 study of Gedeptin , targeting advanced...
Globe Newswire•5 months ago
GeoVax to Host Conference Call at 4:30 PM ET ATLANTA, GA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company...
Globe Newswire•5 months ago